Dr. Evan Cole Lewis is a Pediatric Neurologist and Clinical Neurophysiologist with expertise in epilepsy, epilepsy surgery, electroencephalography (EEG), teleneurology and medical cannabis for the treatment of neurologic disorders. Dr. Lewis is the director of the Neurology Centre of Toronto (NCT) which he established in January 2017. At NCT, Dr. Lewis treats children with a variety of neurological disorders and he also treats adults for concussion, headache and epilepsy.
Dr. Lewis’ interest in medical cannabis began in 2013 while training at Miami Children’s Hospital – one of the major sites for the Epidiolex trials. He has significant clinical experience with medical cannabis in adults and children and is a member of the Canadian Consortium for the Investigation of Cannabinoids (CCIC), Canadian Childhood Cannabinoid Clinical Trials (C4T), and the Cannabinoid Research Initiative of Saskatchewan (CRIS).
Dr Raphael Mechoulam: the chemist responsible for isolating Tetrahydrocannabinol addressed attendees in the keynote speech at the International Cannabis Business Conference in Berlin to explain his cannabis research which unleashed the secrets of the cannabis plant.
Best known for his discovery of tetrahydrocannabinol (THC), one of the 113 known cannabinoids found in the cannabis plant. Mechoulam jumpstarted the medical revolution which has transformed the debate around cannabis and the lives of so many people.